It appears that your browser has cookies disabled.
The website requires your browser to enable cookies in order to login.
Please enable cookies and reload this page.
Advancing Cancer Diagnostics, Improving Lives
Select Your Country/Region
Your location doesnt match the address (URL), do you want to change it?
Each country/region may have its own set of regulatory requirements and medical practices. The information found on each country version of our website is specific to and applicable for only that country/region. This includes (but is not limited to) all product details/availability, documentation, pricing, and promotions.
Antigen Background Programmed death-ligand 1 (PD-L1), CD274 or B7 Homolog 1(B7-H1) is a protein encoded by the CD274 gene. When bound to its ligands, PD-1 and B7.1, it plays an immunosuppressive role by inhibiting T-cell activity. Overexpression of PD-L1 by cancer cells may enable them to evade the host immune response, conferring a growth advantage to such tumors. PD-L1 expression levels detected by immunohistochemistry can therefore be of prognostic value in some types of cancer.
PD-L1 is recommended for the detection of specific antigens of interest in normal and neoplastic tissues, as an adjunct to conventional histopathology using nonimmunologic histochemical stains.
Disclaimer PD-L1 is recommended for the detection of specific antigens of interest in normal and neoplastic tissues, as an adjunct to conventional histopathology using non-immunologic histochemical stains.
